BGB-A333, an anti-PD-L1 monoclonal antibody, in combination with tislelizumab in patients with urothelial carcinoma

J. Martin Liberal, P. C. Fong, V. Moreno, S. Frentzas, J. Desai, T. Meniawy, B. Markman, M. Voskoboynik, N. Budha, J. Wu, W. Shen, M. Singh, E. Calvo

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)S468-S469
Number of pages2
JournalAnnals of Oncology
Volume31
DOIs
Publication statusPublished - Sept 2020
Externally publishedYes
EventESMO Virtual Congress 2020 - , Virtual
Duration: 19 Sept 202021 Sept 2020

Cite this